Northwestern Medicine uses new minimally invasive technique for melanoma
At first, Krista Easom figured the little red bump on her foot was nothing more than a blister.
Source: innovationtoronto.com
Jeffreys Weber News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jeffreys Weber. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jeffreys Weber Today - Breaking & Trending Today
Moderna Announces Data to be presented at 2024 ASCO Annual Meeting
CAMBRIDGE - Moderna, Inc. today announced that three abstracts on mRNA-4157 , an investigational mRNA individualized neoantigen therapy, have been accepted for presentation at the 2024 American...
Source: marketscreener.com
Cancer Vaccine Could Go 'Above and Beyond Standard of Care' For Patients
Moderna and Merck have initiated V940-001, a phase 3 study evaluating vaccine mRNA-4157 and anti-PD-1 therapy Keytruda as postsurgical treatment for stage 2B to 4 melanoma.
Source: curetoday.com
Dr Weber on the Background of the KEYNOTE-942 Trial in High-Risk Melanoma
Jeffrey S. Weber, MD, PhD, discusses the background for the KEYNOTE-942 trial, which was conducted in resected high-risk melanoma.
Source: onclive.com
ctDNA Patterns May Predict Outcomes Achieved With mRNA-4157 Plus Pembrolizumab in High-Risk Melanoma
Jeffrey S. Weber, MD, PhD, highlighted key efficacy findings from the mRNA-4157-P201/KEYNOTE-942 trial, expanded on the potential utility of longitudinal ctDNA dynamics as a kinetic marker for clinical outcomes in melanoma, and underscored the importance of continued research on mRNA vaccines paired with standard PD-1 therapy across cancer types.
Source: onclive.com